Primary open-angle glaucoma (POAG) is a leading cause of blindness worldwide. To identify new susceptibility loci, we performed meta-analysis on genome-wide association study (GWAS) results from eight independent studies from the United States (3,853 cases and 33,480 controls) and investigated the most significantly associated SNPs in two Australian studies (1,252 cases and 2,592 controls), three European studies (875 cases and 4,107 controls) and a Singaporean Chinese study  (1,037 cases and 2,543 controls) TXNRD2 (odds ratio (OR) = 0.78, P = 4.05 × 10 −11 ) encoding a mitochondrial protein required for redox homeostasis; rs7137828[T] in ATXN2 (OR = 1.17, P = 8.73 × 10 −10 ); and rs2745572[A] upstream of FOXC1 (OR = 1.17, P = 1.76 × 10 −10 ). Using RT-PCR and immunohistochemistry, we show TXNRD2 and ATXN2 expression in retinal ganglion cells and the optic nerve head. These results identify new pathways underlying POAG susceptibility and suggest new targets for preventative therapies.
1 9 0 VOLUME 48 | NUMBER 2 | FEBRUARY 2016 Nature GeNetics l e t t e r s sets except OHTS, controls had an intraocular pressure (IOP) of <21 mm Hg (Supplementary Table 2 ). For each data set, site-specific quality control (sample and genotype call rates ≥95%), principalcomponents analysis (EIGENSTRAT 11 ) and imputation (IMPUTE2 (ref. 12) or MACH 13, 14 ) were completed using the 1000 Genomes Project reference panel (March 2012) ( Supplementary Table 3 and Supplementary Note). Imputed variants with minor allele frequencies <5% or imputation quality scores (r 2 ) <0.7 were removed before analysis. Dosage data, in the form of estimated genotypic probabilities, were analyzed in ProbABEL 15 for each data set using logistic regression models, adjusting for age, sex, any significant eigenvectors (P < 0.05) and study-specific covariates. The genomic inflation (λ) was less than 1.05 for each individual data set ( Supplementary Fig. 1) . Estimated genotypic probabilities for 6,425,680 variants underwent metaanalysis in Metal 16 using the inverse variance-weighted method.
To confirm that the results were not skewed by a particular data set, we completed a sensitivity analysis by selectively removing each data set in turn and carrying out meta-analysis on the remaining seven data sets. The odds ratios from each grouping of seven data sets were highly correlated with the results obtained from all eight data sets ( Supplementary Fig. 2) .
The stage 1 genome-wide association results are shown in Supplementary Figure 3 , and the association results for all SNPs with P < 1 × 10 −5 are shown in Supplementary Table 4 . The association for one SNP (rs2745572[A]) located in a region on 6p 50 kb 5′ to FOXC1 reached genome-wide significance (OR = 1.25, P = 2.36 × 10 −9 ) in stage 1 ( Table 1) . Additionally, 873 SNPs, including SNPs located in regions not previously associated with POAG on 1p, 2p, 2q, 5p, 6p, 6q, 10q, 12q, 20p and 22p, had association P < 1 × 10 −5 ( Supplementary Table 4 ). Figure 1 Association results for the regions reaching genome-wide significance after stage 2. These plots show the regional association and recombination rates for the top SNPs in the discovery cohort (NEIGHBORHOOD; 3,853 cases and 33,480 controls) after meta-analysis with data for these SNPs from ANZRAG (1,155 cases and 1,992 controls).
In each plot, the solid diamond represents the top ranked SNP in the region, identified on the basis of two-sided P values. Pairwise correlation (r 2 ) between the top SNP and the other SNPs in the region is indicated by color. Blue spikes show the estimated recombination rates. The box underneath each plot shows the gene annotations in the region. Each plot was created using LocusZoom for the top ranked SNP in each region with a 400-kb region surrounding it. (a) The top SNP for this plot is rs2745572 on chromosome 6 upstream of FOXC1 with association P = 6.50 × 10 −11 . (b) The top SNP for this plot is rs7137828 on chromosome 12 within ATXN2 with association P = 9.20 × 10 −9 . (c) The top SNP for this plot is rs35934224 on chromosome 22 within TXNRD2 with association P = 1.08 × 10 −9 .
npg l e t t e r s Next, we investigated the associations of the most significant stage 1 SNPs (P < 1 × 10 −5 ) in a replication data set of individuals of European ancestry from Australia (ANZRAG; 1,155 cases and 1,992 controls) (Supplementary Note) and performed a meta-analysis of these SNPs in the NEIGHBORHOOD and ANZRAG data sets using effect sizes and their standard errors (stage 2). In the meta-analysis, SNPs in new regions 50 kb 5′ to FOXC1 (top SNP rs2745572[A], OR = 1.23, P = 6.5 × 10 −11 ), within intron 14 of ATXN2 (top SNP rs7137828[T], OR = 1.18, P = 9.2 × 10 −9 ) and within intron 11 of TXNRD2 (top SNP rs35934224[T], OR = 0.77, P = 1.8 × 10 −9 ) reached genomewide significance ( Table 1 and Supplementary Table 5 ). The regional association results for these SNPs are shown in Figure 1 .
For each of the three new regions reaching genome-wide significance after stage 2, we further examined their association with POAG in a second Australian data set (BMES; 107 cases and 600 controls), three European data sets (875 cases and 4,107 controls in total) and a study of Singaporean Chinese (1,037 cases and 2,543 controls) (stage 3). The association for all three top SNPs exceeded genome-wide significance in meta-analysis of all data sets ( Fig. 2 and Supplementary  Fig. 4 Tables 6 and 7) . The top SNP within ATXN2 (rs7137828) is very rare in the Singaporean Chinese population and thus could not be evaluated.
SNPs in the GAS7 region, previously associated with IOP, a quantitative trait that when elevated is a risk factor for glaucoma [17] [18] [19] , were significantly associated with POAG after stage 2 (top SNP rs9897123[T], OR = 0.83, P = 5.85 × 10 −10 ) ( Table 1) . Other POAGassociated loci identified in recent studies [5] [6] [7] [8] [9] were also confirmed, including TMCO1, CDKN2B-AS1, SIX6, ABCA1 and AFAP1 ( Table 1 and Supplementary Table 8 ). SNPs in PMM2 recently identified in Chinese individuals with POAG 9 were nominally associated with POAG (top SNP rs12444233[T], OR = 1.13, P = 0.0016).
POAG, like many complex human diseases, displays clinical subphenotypes 20, 21 . In particular, optic nerve degeneration in POAG can occur without elevation of IOP, a clinical subtype defined as normal-tension glaucoma (NTG) 22 . The NEIGHBORHOOD POAG data set included 725 NTG cases (maximum IOP ≤21 mm Hg) and 1,868 high-tension glaucoma (HTG) cases (maximum IOP >21 mm Hg) (pretreatment IOP data were not available for 1,260 cases). Meta-analysis of NTG cases (using all the controls from the data sets with NTG cases) identified one new associated locus on chromosome 12q (rs2041895[C], OR = 1.48, P = 2.41 × 10 −8 ) in stage 1 (Supplementary Fig. 5 and Supplementary Table 9 ). The direction of effect was consistent (OR = 1.15) in the ANZRAG NTG data set but did not reach significance (P = 0.11) and the combined association result (NEIGHBORHOOD + ANZRAG) fell just short of genomewide significance (P = 8.01 × 10 −8 ), possibly owing to a smaller number of NTG cases in the ANZRAG data set (n = 363). In the NEIGHBORHOOD discovery data set, we confirmed previous NTG associations on 9p (ref. Fig. 6 and Supplementary Table 10 ). The SNPs in the FOXC1 region associated with POAG overall were also significant in the NEIGHBORHOOD HTG subgroup (most significant SNP rs2317961, OR = 0.76, P = 2.58 × 10 −8 ).
To assess the possible functional effects of SNPs at the three newly identified POAG-associated loci, we accessed and applied data from l e t t e r s the Encyclopedia of DNA Elements (ENCODE) 24 , SCAN (expression quantitative trait loci, eQTLs) 25 , Genevar (eQTLs) 26 , GTEx (eQTLs) 27 and RegulomeDB v2 (refs. 28, 29) databases. After stage 2, seven SNPs reached genome-wide significance in the FOXC1 region ( Supplementary Table 5 ), and all seven of these are located 50 kb 5′ to FOXC1 in a region annotated by ENCODE as regulatory (Supplementary Fig. 7) and are associated with enhancers in several cell types (P = 0.01, RegulomeDB v2). The most significant SNP (rs2745572) is evolutionarily conserved (GERP score = 1.8) and alters a BARHL1 transcription factor binding site (RegulomeDB v2).
In zebrafish, Barhl1 is expressed in distinct retinal cell lineages and is differentially regulated by Atoh7 (ref. 30 ), a retina-specific transcription factor that has been previously associated with optic nerve area 31 and glaucoma 32 . In the NEIGHBORHOOD meta-analysis, we found nominal evidence for association between ATOH7 and POAG (top SNP rs1867567[A], OR = 1.07, P = 0.042). Four SNPs in the ATXN2 region were significantly associated with POAG after stage 2 ( Supplementary Table 5 ). These SNPs are located in genomic regions enriched for enhancers in lymphoid cells (P = 0.01, RegulomeDB v2). The most significant SNP (rs7137828) is located in an SP1 transcription factor binding site, and another associated SNP (rs653178), which is in linkage disequilibrium (LD) with rs7137828 (r 2 >0.8, European ancestry), is located in an ESR2 (estrogen receptor 2) binding site. Both SP1 and ESR2 are expressed in human and rat retinal cells 33, 34 and could influence expression of ATXN2 (ref. 35) .
The TXNRD2 region that includes 22 SNPs associated at the genome-wide significance level after stage 2 ( Supplementary Table 5 ) is significantly enriched for enhancers (P = 1 × 10 −6 , RegulomeDB v2) and DNase I hypersensitivity sites (P = 4.3 × 10 −5 , RegulomeDB v2) in multiple cell types. Additionally, six of the TXNRD2 SNPs are cis eQTLs significantly associated with TXNRD2 transcript levels in MuTHER (Multiple-Tissue Human Expression Resource) twins 36 in lymphoblasts and skin (P = 1 × 10 −8 , Genevar; Supplementary Fig. 8) .
The top SNP (rs35934224) is also an eQTL in skin using RNA sequencing (RNA-seq) and 1000 Genomes Project imputation (P = 2.32 × 10 −13 ) (ref. 37 ). All 22 TXNRD2 SNPs are significant cis eQTLs (P < 1 × 10 −4 ) in the GTEx database 27 in thyroid tissue, and 19 are significant eQTLs in tibial nerve tissue (Supplementary Fig. 9) . The most significant TXNRD2 SNP (rs35934224) is located in a binding site for NRSF (neuron-restrictive silencer factor), also known as REST (repressor element 1-silencing transcription factor), a transcription factor that potently protects neurons from oxidative stress 38 .
FOXC1 is a member of the forkhead family of transcription factors, and rare coding-sequence mutations (missense, nonsense and copy number variation (CNV)) are known to cause anterior segment dysgenesis and early-onset glaucoma with dominant inheritance 39, 40 . FOXC1 has not been previously implicated in common adult-onset forms of glaucoma, including POAG or HTG. Interestingly, association over GMDS, located 3′ to FOXC1, has been identified in a study using some of the same samples analyzed here 8 . In our study, we found genome-wide significant association adjacent to FOXC1 in the 5′ regulatory region and less significant association in GMDS (top SNP rs9378638[C], OR = 0.83, P = 7.50 × 10 −6 ). The top SNPs in the two regions are approximately 400 kb apart and are not in LD. Conditional analysis confirmed that the odds ratio and P value for the significantly associated SNPs 5′ to FOXC1 are unchanged by conditioning on the GMDS peak SNP, suggesting that these are independent associations (Supplementary Fig. 10) . The 5′ regulatory SNPs associated with POAG and HTG identified by this study could be involved in regulation of FOXC1 expression.
The ATXN2 and TXNRD2 genomic regions have not been previously associated with POAG or with any glaucoma-related quantitative traits such as optic nerve parameters or IOP. Expansions of a CAG repeat in ATXN2 can cause spinocerebellar ataxia 2 with optic atrophy, and intermediate-length expansions can contribute to the development of amyotrophic lateral sclerosis (ALS) 41 . Very recently, two other genes known to be responsible for Mendelian forms of NTG have also been shown to contribute to ALS 42, 43 . The ATXN2-SH2B3 region has been associated with retinal venular caliber in individuals with European ancestry 44 . We analyzed the expression of ATXN2 mRNA in normal human ocular tissues by RT-PCR and found expression in the cornea, trabecular meshwork, ciliary body, retina and optic nerve Staining was also observed in cells in the optic nerve head (lower panels), indicative of astrocytes that form pial columns (arrows; right-most lower panel). Punctate staining was also observed in the optic nerve head (arrowheads; lower panels). For each antibody, at least three sections from six eyes were assessed. No staining (not even punctate staining) was observed in control tissue with no primary antibody (data not shown). Blue, DAPI. In all rows, the right-most panels show magnified views of the boxed regions in the center panels. Scale bars: upper left and center panels in a and b, 20 µm; lower left and center panels in a, 15 µm; lower left and center panels in b, 25 µm; right-most panels in a and b, 5 µm. l e t t e r s ( Supplementary Fig. 11 ). Immunolabeling of sections of a normal mouse eye showed evidence of ATXN2 in the retinal ganglion cells and optic nerve ( Fig. 3) .
TXNRD2 encodes thioredoxin reductase 2, a mitochondrial protein necessary for reducing the levels of damaging reactive oxygen species generated by oxidative phosphorylation and other mitochondrial functions 45 . Cellular oxidative stress has been hypothesized as a cause of retinal ganglion cell dysfunction in glaucoma 46 , and overexpression of thioredoxin 2, the substrate of thioredoxin reductase 2 (encoded by TXNRD2), increased retinal ganglion cell survival in an experimental glaucoma model 47 . We confirmed by RT-PCR that TXNRD2 is expressed in normal human ocular tissue ( Supplementary  Fig. 11) , including the retina and optic nerve. Immunolabeling in mice showed strong staining in retinal ganglion cells as well as in the optic nerve (Fig. 3) . These data suggest that the reduction of reactive oxygen species levels by TXNRD2 could prevent mitochondrial dysfunction and retinal ganglion cell apoptosis in glaucoma. To our knowledge, TXNRD2 is the first mitochondrial protein associated with glaucoma risk.
In this study, we identified common variants near FOXC1, ATXN2 and TXNRD2 as new risk loci for POAG. These genes suggest new pathways that may contribute to glaucoma development, including abnormal ocular development (FOXC1), neurodegeneration (ATXN2) and mitochondrial dysfunction secondary to accumulating reactive oxygen species (TXNRD2). Targeting these pathways could lead to effective and potentially preventative glaucoma therapies.
